Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic HSCT conditioning for children and adolescents with acute lymphoblastic leukemia
NL-OMON54836Phase 3Recruiting
- Sponsor
- St. Anna Children's Cancer Research Institute
- Start
- Oct 2016
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of etoposide, fludarabine, thiotepa, busulfan in acute lymphoblastic leukemia (ALL), sponsored by St. Anna Children's Cancer Research Institute. Started Oct 2016; status: recruiting.
02
Drugs
etoposidefludarabinethiotepabusulfan
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NL-OMON54836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54836.